Conexeu Sciences Inc. (CNXU)

Market Cap	333.56M
Revenue (ttm)	n/a
Net Income	-5.35M
EPS	-0.35
Shares Out	25.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,246
Open	13.21
Previous Close	13.07
Day's Range	12.72 - 13.31
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CNXU

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tiss...

• Founded: 2022
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: CNXU
• Website: https://www.conexeu.com